Affimed N.V. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ADAP
Adaptimmune Therapeutics plc |
$0.58 | $260.61 M | -1.4 | 449 | $60.28 M |
ADCT
ADC Therapeutics SA |
$2.01 | $329.09 M | -1.23 | 273 | $69.56 M |
AGEN
Agenus Inc. |
$2.75 | $348.59 M | 1.43 | 389 | $156.31 M |
APTO
Aptose Biosciences Inc. |
$0.25 | $16.66 M | -0.15 | 35 | $0 |
CRVS
Corvus Pharmaceuticals, Inc. |
$4.90 | $126.98 M | -3.98 | 28 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.67 | $1.12 B | -5.11 | 174 | $0 |
EFTR
eFFECTOR Therapeutics, Inc. |
$0.00 | $6.16 M | -0.1 | 14 | $0 |
ELEV
Elevation Oncology, Inc. |
$0.56 | $192.87 M | -4.15 | 29 | $0 |
HEPA
Hepion Pharmaceuticals, Inc. |
$0.50 | $6.02 M | -0.12 | 22 | $0 |
INZY
Inozyme Pharma, Inc. |
$2.93 | $286.39 M | -3.43 | 59 | $0 |
LPTX
Leap Therapeutics, Inc. |
$2.91 | $85.71 M | -1.79 | 54 | $0 |
MREO
Mereo BioPharma Group plc |
$3.81 | $479.72 M | -22.8 | 33 | $10.00 M |
PDSB
PDS Biotechnology Corporation |
$1.64 | $106.92 M | -2.13 | 25 | $0 |
PIRS
Pieris Pharmaceuticals, Inc. |
$13.60 | $13.53 M | -0.9 | 46 | $42.81 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
TERN
Terns Pharmaceuticals, Inc. |
$5.80 | $462.44 M | -5.67 | 66 | $0 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.58 | $169.62 M | -1.51 | 127 | $0 |